Number of Vials of Remdesivir, Tocilizumab and Amphotericin B Supplied for Treatment of COVID-19 Infections by Pharmaceutical Companies Against Allocation Given by Central Government in Karnataka (As on 25.07.2021) | |||
State | Remdesivir | Tocilizumab | Amphotericin B |
Karnataka | |||
India |